Internet as Supplier: Preventing Adolescent Use of Non-Medical Addictive Rx

互联网作为供应商：防止青少年使用非医疗成瘾药物

基本信息

批准号：
7651889
负责人：
AMELIA M ARRIA
金额：
$ 49.96万
依托单位：
TREATMENT RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
起止时间：
2009-09-01 至 2011-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7651889
关键词：
Administrator Adolescent Advertising Age Attention Characteristics Clinical Computers Confidentiality Data Data Collection Dependence Development Diazepam Drug Controls Drug Prescriptions Drug Prevention Program Drug abuse Drug usage Equipment and supply inventories Face Family Fostering Foundations Friends Future Health Health Services Research Hearing Internet Interview Investigation Lead Legal Marketing Medical Monitor National Institute of Drug Abuse Nature Online Systems Opioid Oxycodone Paper Participant Pattern Pharmaceutical Preparations Pharmacy facility Physicians Play Policies Prevalence Procedures Protocols documentation Relapse Reporting Research Research Institute Residential Treatment Respondent Risk Role Sales Sampling Sanofi brand of zolpidem tartrate Schools Self-Administered Severities Site Source Substance abuse problem Surveys Teenagers Testing Tranquilizing Agents United States Substance Abuse and Mental Health Services Administration Vicodin Xanax Youth addiction adolescent drug use age group base college cost effective demographics design high risk news peer policy implication prevent programs public health relevance research study sedative theories treatment program web interface

项目摘要

DESCRIPTION (provided by applicant): Adolescent non-medical use of highly addictive prescription opioid drugs, such as Vicodin and Oxycontin; and tranquilizers, such as Valium and Xanax, is increasing. Although the reasons for increasing adolescent non-medical use of addictive prescription drugs are not known, we do know that they are widely advertised and sold over the internet without prescription. The Treatment Research Institute and Drug Strategies have conducted research on internet drug sales for the past four years and we believe that "non-prescription websites (NPWs)" may be one important contributing factor to increasing adolescent use of these drugs. There has been no research on the role of the internet in supplying prescription medications to adolescents without a prescription. This revised RO1 will continue our investigations of the use of internet and other sources for drug purchase by high risk adolescents currently in residential treatment programs. We have a revised 30-minute data collection protocol using well-validated items from the CASI (Meyers et al., 1995 - 2007) that will be administered via a well-tested and engaging web interface (BubbleMonkey) to a purposive sample of 2000 adolescents (12 - 17) from 30 programs in a two-year data collection period. The data collection has been designed to completely protect confidentiality. The study has three primary aims: 1. To determine whether internet purchase is a significant source of drug availability for adolescents with serious substance abuse and addiction problems. We operationally define "significant" as a prevalence rate of 20 percent or higher in this sample. 2. To determine whether internet drug availability is associated with a significant proportion of relapses following efforts to stop drug use. Again, we operationally define "significant as a prevalence rate of 20 percent or higher. 3. To explore whether use of internet websites and other sources, differs as a function of demographic and drug use characteristics among these high-risk adolescents. Information is urgently needed about the relationship between rising rates of adolescent non- medical use of prescription drugs and internet websites that market those drugs without a prescription. This study will be the first to obtain this information directly from adolescents about internet sources of drug supply. PUBLIC HEALTH RELEVANCE: Adolescent non-medical use of highly addictive prescription opioid drugs, such as Vicodin and Oxycontin and tranquilizers such as Valium and Xanax, continues at high levels. These substances are widely advertised and sold over the internet without prescription, perhaps fostering adolescent use. This study will obtain information directly from adolescents about their use of the internet and other sources to obtain drugs.

描述（由申请人提供）：青少年非医疗使用高度成瘾的处方阿片类药物，如维柯丁和奥施康定；安定（Valium）和阿普唑仑（Xanax）等镇静剂的使用量正在增加。尽管青少年非医疗用途成瘾处方药增加的原因尚不清楚，但我们确实知道这些药物在互联网上广泛宣传和销售，无需处方。治疗研究所和药物策略在过去四年里对互联网药品销售进行了研究，我们认为“非处方网站（NPW）”可能是增加青少年使用这些药物的重要因素之一。目前还没有关于互联网在向没有处方的青少年提供处方药方面的作用的研究。修订后的 RO1 将继续调查目前接受住院治疗计划的高危青少年使用互联网和其他渠道购买药物的情况。我们使用来自 CASI 的经过充分验证的项目（Meyers 等人，1995 - 2007 年）修订了 30 分钟数据收集协议，该协议将通过经过充分测试且引人入胜的网络界面（BubbleMonkey）对 2000 年的有目的样本进行管理在两年的数据收集期内，来自 30 个项目的青少年（12 - 17 岁）。数据收集的目的是完全保护机密性。该研究有三个主要目的： 1. 确定互联网购买是否是有严重药物滥用和成瘾问题的青少年获得药物的重要来源。我们在操作上将“显着”定义为该样本中的患病率为 20% 或更高。 2. 确定互联网药物供应是否与戒毒后很大一部分复发有关。再次，我们在操作上将“显着”定义为患病率达到 20% 或更高。 3. 探讨这些高危青少年对互联网网站和其他来源的使用是否因人口和药物使用特征而有所不同。这项研究将是第一个直接从青少年那里获得有关互联网药物供应来源的信息的研究。公共卫生相关性：青少年对高度成瘾的处方阿片类药物（如维柯丁和奥施康定）以及镇静剂（如安定和 Xanax）的非医疗使用仍然处于高水平。这些物质在没有处方的情况下在互联网上广泛宣传和销售，可能会促进青少年的使用。这项研究将直接从青少年那里获取有关他们使用互联网和其他来源获取毒品的信息。